Welcome ...

Change of Company Name Announcement

As of 1 July 2010, we are proud to announce that Technipro Marketing is now divided into two companies and will comprise of Technipro-PulmoMed Pty Ltd (ABN 54 002 730 421) and it’s subsidiary, SMR-Tech Pty Ltd.  (ABN 12 103 215 603). The subdivision is due to the expansion of our business activities which now include product lines beyond the traditional Technipro cystic fibrosis activities.

Technipro-PulmoMed will now focus entirely on our products for the comprehensive management of Cystic Fibrosis , including PARI ® nebulisers and accessories, Astra-Tech, Pari & Flutter® mucus clearance devices, Pinnacle® peak flow meters, VitABDECK®  multi-vitamins, and Panzytrat ® pancreatic enzymes.

Our new Technipro-PulmoMed logo that reflects the new change:

tech-pulmomed-logo.jpg

 SMR-Tech Pty Ltd will focus on our sports medicine, exercise physiology & rehabilitation products which include h/p/Cosmos® treadmills, Cortex® CPX systems, and InBody® body composition analysers.

Our new SMR-Tech logo is:

smr-tech logo

There has been no change in management, and we will be providing the same products and fine service on which we have built our reputation in the industry.  

We are currently working on a new website to accommodate these two companies and appreciate your patience during this progress.  In the meantime, our old website will still be up and running and you can continue to place orders for Technipro-PulmoMed via our Order Form page.  At the same time, we will be changing our email addresses, and will keep you updated when these change.  The old email addresses will continue to be operational for the near future.  Our web domain www.technipro.com will remain unchanged.

For enquiries regarding either of these companies, please contact
info@technipro.com.au or (02) 9897 5899.  (Please note the new email address)

Just some of our world renowned products for comprehensive disease management of cystic fibrosis, chronic respiratory diseases, dysphagia & swallowing disorders, as well as state of the art devices for cardiopulmonary stress testing and gas exchange analysis are:

Technipro-Pulmomed is committed to advancing care for CF & respiratory diseases and each year sponsors scholarships for allied health professionals in conjunction with Cystic Fibrosis Australia (CFA) and
Australian & New Zealand Society of Respiratory Science (ANZSRS).